Furthermore, B7-H3-targeting CAR-T cells were demonstrated to have anti-tumor effects against in vitro tumor spheres derived from surgically resected chordoma tissue, demonstrating a potential role for CAR-T cell therapy in patients expressing this antigen [251]. The gene discussed is CD276; the disease is chordoma.